mic test against s aureus Search Results


99
ATCC penetratin against s aureus reports mic values
Penetratin Against S Aureus Reports Mic Values, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mic+test+against+s+aureus/pm23085001-181-7-24?v=ATCC
Average 99 stars, based on 1 article reviews
penetratin against s aureus reports mic values - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

99
ATCC staphylococcus aureus emrsa 15 mic
Examples of Cannabis sativa constituents that have been documented to possess anti-bacterial, anti-fungal, and/or anti-protozoal activities *.
Staphylococcus Aureus Emrsa 15 Mic, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mic+test+against+s+aureus/pmc08945038-0-36-57?v=ATCC
Average 99 stars, based on 1 article reviews
staphylococcus aureus emrsa 15 mic - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

99
ATCC mic tests against s mutans atcc 25175
Examples of Cannabis sativa constituents that have been documented to possess anti-bacterial, anti-fungal, and/or anti-protozoal activities *.
Mic Tests Against S Mutans Atcc 25175, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mic+test+against+s+aureus/10__21608_slash_ejabf__2025__437648-286-0-5?v=ATCC
Average 99 stars, based on 1 article reviews
mic tests against s mutans atcc 25175 - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

93
ATCC s aureus
Examples of Cannabis sativa constituents that have been documented to possess anti-bacterial, anti-fungal, and/or anti-protozoal activities *.
S Aureus, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mic+test+against+s+aureus/pm40076338-189-12-47?v=ATCC
Average 93 stars, based on 1 article reviews
s aureus - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier

97
ATCC mic against mrsa atcc
In vitro antimicrobial bioassay of actinomycetia extracts against model pathogens and MDR pathogens: ( A ) Antimicrobial activity by spot inoculation (I,II) and well diffusion method (III–V) against model pathogens: (I) Candida albicans (MTCC 227). (II,III) <t>MRSA</t> (ATCC 43300). (IV) Klebsiella pneumonia (MTCC 3384); (V) Pseudomonas aeruginosa (MTCC 741). ( B ) Bioactivity of fermentation broth of actinomycetia isolates against model pathogens, based on triplicate experiments. ( C ) Antimicrobial activity by well diffusion method against MDR pathogens: (I,II) Pseudomonas aeruginosa . (III–V) Enterococcus faecalis . (VI–VIII) Escherichia coli . ( D ) Bioactivity of fermentation broth of actinomycetia isolates against 3 MDR pathogens, based on triplicate experiments, against: GNR7; Enterococcus faecalis ; GNR18; Pseudomonas aeruginosa ; and GNR19; Escherichia coli .
Mic Against Mrsa Atcc, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mic+test+against+s+aureus/pmc10456813-373-10-13?v=ATCC
Average 97 stars, based on 1 article reviews
mic against mrsa atcc - by Bioz Stars, 2026-08
97/100 stars
  Buy from Supplier

99
ATCC doses against s aureus strain atcc 25923
In vitro antimicrobial bioassay of actinomycetia extracts against model pathogens and MDR pathogens: ( A ) Antimicrobial activity by spot inoculation (I,II) and well diffusion method (III–V) against model pathogens: (I) Candida albicans (MTCC 227). (II,III) <t>MRSA</t> (ATCC 43300). (IV) Klebsiella pneumonia (MTCC 3384); (V) Pseudomonas aeruginosa (MTCC 741). ( B ) Bioactivity of fermentation broth of actinomycetia isolates against model pathogens, based on triplicate experiments. ( C ) Antimicrobial activity by well diffusion method against MDR pathogens: (I,II) Pseudomonas aeruginosa . (III–V) Enterococcus faecalis . (VI–VIII) Escherichia coli . ( D ) Bioactivity of fermentation broth of actinomycetia isolates against 3 MDR pathogens, based on triplicate experiments, against: GNR7; Enterococcus faecalis ; GNR18; Pseudomonas aeruginosa ; and GNR19; Escherichia coli .
Doses Against S Aureus Strain Atcc 25923, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mic+test+against+s+aureus/10__1128_slash_aac__01584___08-122-7-12?v=ATCC
Average 99 stars, based on 1 article reviews
doses against s aureus strain atcc 25923 - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

99
ATCC mic value against staphylococcus aureus atcc 29213
In vitro antimicrobial bioassay of actinomycetia extracts against model pathogens and MDR pathogens: ( A ) Antimicrobial activity by spot inoculation (I,II) and well diffusion method (III–V) against model pathogens: (I) Candida albicans (MTCC 227). (II,III) <t>MRSA</t> (ATCC 43300). (IV) Klebsiella pneumonia (MTCC 3384); (V) Pseudomonas aeruginosa (MTCC 741). ( B ) Bioactivity of fermentation broth of actinomycetia isolates against model pathogens, based on triplicate experiments. ( C ) Antimicrobial activity by well diffusion method against MDR pathogens: (I,II) Pseudomonas aeruginosa . (III–V) Enterococcus faecalis . (VI–VIII) Escherichia coli . ( D ) Bioactivity of fermentation broth of actinomycetia isolates against 3 MDR pathogens, based on triplicate experiments, against: GNR7; Enterococcus faecalis ; GNR18; Pseudomonas aeruginosa ; and GNR19; Escherichia coli .
Mic Value Against Staphylococcus Aureus Atcc 29213, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mic+test+against+s+aureus/10__1080_slash_00397911__2013__845902-79-9-14?v=ATCC
Average 99 stars, based on 1 article reviews
mic value against staphylococcus aureus atcc 29213 - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

99
ATCC minimum inhibitory concentration mic values against candida albicans
In vitro antimicrobial bioassay of actinomycetia extracts against model pathogens and MDR pathogens: ( A ) Antimicrobial activity by spot inoculation (I,II) and well diffusion method (III–V) against model pathogens: (I) Candida albicans (MTCC 227). (II,III) <t>MRSA</t> (ATCC 43300). (IV) Klebsiella pneumonia (MTCC 3384); (V) Pseudomonas aeruginosa (MTCC 741). ( B ) Bioactivity of fermentation broth of actinomycetia isolates against model pathogens, based on triplicate experiments. ( C ) Antimicrobial activity by well diffusion method against MDR pathogens: (I,II) Pseudomonas aeruginosa . (III–V) Enterococcus faecalis . (VI–VIII) Escherichia coli . ( D ) Bioactivity of fermentation broth of actinomycetia isolates against 3 MDR pathogens, based on triplicate experiments, against: GNR7; Enterococcus faecalis ; GNR18; Pseudomonas aeruginosa ; and GNR19; Escherichia coli .
Minimum Inhibitory Concentration Mic Values Against Candida Albicans, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mic+test+against+s+aureus/pmc05449922-29-11-19?v=ATCC
Average 99 stars, based on 1 article reviews
minimum inhibitory concentration mic values against candida albicans - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

98
ATCC antimicrobial activity against e coli atcc 11775
In vitro antimicrobial bioassay of actinomycetia extracts against model pathogens and MDR pathogens: ( A ) Antimicrobial activity by spot inoculation (I,II) and well diffusion method (III–V) against model pathogens: (I) Candida albicans (MTCC 227). (II,III) <t>MRSA</t> (ATCC 43300). (IV) Klebsiella pneumonia (MTCC 3384); (V) Pseudomonas aeruginosa (MTCC 741). ( B ) Bioactivity of fermentation broth of actinomycetia isolates against model pathogens, based on triplicate experiments. ( C ) Antimicrobial activity by well diffusion method against MDR pathogens: (I,II) Pseudomonas aeruginosa . (III–V) Enterococcus faecalis . (VI–VIII) Escherichia coli . ( D ) Bioactivity of fermentation broth of actinomycetia isolates against 3 MDR pathogens, based on triplicate experiments, against: GNR7; Enterococcus faecalis ; GNR18; Pseudomonas aeruginosa ; and GNR19; Escherichia coli .
Antimicrobial Activity Against E Coli Atcc 11775, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mic+test+against+s+aureus/pmc06001651-120-8-12?v=ATCC
Average 98 stars, based on 1 article reviews
antimicrobial activity against e coli atcc 11775 - by Bioz Stars, 2026-08
98/100 stars
  Buy from Supplier

99
ATCC 33591 initial count 1 2 × 109 test recovered
In vitro antimicrobial bioassay of actinomycetia extracts against model pathogens and MDR pathogens: ( A ) Antimicrobial activity by spot inoculation (I,II) and well diffusion method (III–V) against model pathogens: (I) Candida albicans (MTCC 227). (II,III) <t>MRSA</t> (ATCC 43300). (IV) Klebsiella pneumonia (MTCC 3384); (V) Pseudomonas aeruginosa (MTCC 741). ( B ) Bioactivity of fermentation broth of actinomycetia isolates against model pathogens, based on triplicate experiments. ( C ) Antimicrobial activity by well diffusion method against MDR pathogens: (I,II) Pseudomonas aeruginosa . (III–V) Enterococcus faecalis . (VI–VIII) Escherichia coli . ( D ) Bioactivity of fermentation broth of actinomycetia isolates against 3 MDR pathogens, based on triplicate experiments, against: GNR7; Enterococcus faecalis ; GNR18; Pseudomonas aeruginosa ; and GNR19; Escherichia coli .
33591 Initial Count 1 2 × 109 Test Recovered, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mic+test+against+s+aureus/us08420627-229-12-11?v=ATCC
Average 99 stars, based on 1 article reviews
33591 initial count 1 2 × 109 test recovered - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

98
ATCC compounds against reference bacterial strains staphylococcus aureus
In vitro antimicrobial bioassay of actinomycetia extracts against model pathogens and MDR pathogens: ( A ) Antimicrobial activity by spot inoculation (I,II) and well diffusion method (III–V) against model pathogens: (I) Candida albicans (MTCC 227). (II,III) <t>MRSA</t> (ATCC 43300). (IV) Klebsiella pneumonia (MTCC 3384); (V) Pseudomonas aeruginosa (MTCC 741). ( B ) Bioactivity of fermentation broth of actinomycetia isolates against model pathogens, based on triplicate experiments. ( C ) Antimicrobial activity by well diffusion method against MDR pathogens: (I,II) Pseudomonas aeruginosa . (III–V) Enterococcus faecalis . (VI–VIII) Escherichia coli . ( D ) Bioactivity of fermentation broth of actinomycetia isolates against 3 MDR pathogens, based on triplicate experiments, against: GNR7; Enterococcus faecalis ; GNR18; Pseudomonas aeruginosa ; and GNR19; Escherichia coli .
Compounds Against Reference Bacterial Strains Staphylococcus Aureus, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mic+test+against+s+aureus/pm19813722__ic901039k_si_016-0-17-24?v=ATCC
Average 98 stars, based on 1 article reviews
compounds against reference bacterial strains staphylococcus aureus - by Bioz Stars, 2026-08
98/100 stars
  Buy from Supplier

99
ATCC zoliflodacin broth microdilution mic test results against e coli atcc 25922
In vitro antimicrobial bioassay of actinomycetia extracts against model pathogens and MDR pathogens: ( A ) Antimicrobial activity by spot inoculation (I,II) and well diffusion method (III–V) against model pathogens: (I) Candida albicans (MTCC 227). (II,III) <t>MRSA</t> (ATCC 43300). (IV) Klebsiella pneumonia (MTCC 3384); (V) Pseudomonas aeruginosa (MTCC 741). ( B ) Bioactivity of fermentation broth of actinomycetia isolates against model pathogens, based on triplicate experiments. ( C ) Antimicrobial activity by well diffusion method against MDR pathogens: (I,II) Pseudomonas aeruginosa . (III–V) Enterococcus faecalis . (VI–VIII) Escherichia coli . ( D ) Bioactivity of fermentation broth of actinomycetia isolates against 3 MDR pathogens, based on triplicate experiments, against: GNR7; Enterococcus faecalis ; GNR18; Pseudomonas aeruginosa ; and GNR19; Escherichia coli .
Zoliflodacin Broth Microdilution Mic Test Results Against E Coli Atcc 25922, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mic+test+against+s+aureus/10__1128_slash_jcm__00567___19-141-6-15?v=ATCC
Average 99 stars, based on 1 article reviews
zoliflodacin broth microdilution mic test results against e coli atcc 25922 - by Bioz Stars, 2026-08
99/100 stars
  Buy from Supplier

Image Search Results


Examples of Cannabis sativa constituents that have been documented to possess anti-bacterial, anti-fungal, and/or anti-protozoal activities *.

Journal: Biomedicines

Article Title: Anti-Microbial Activity of Phytocannabinoids and Endocannabinoids in the Light of Their Physiological and Pathophysiological Roles

doi: 10.3390/biomedicines10030631

Figure Lengend Snippet: Examples of Cannabis sativa constituents that have been documented to possess anti-bacterial, anti-fungal, and/or anti-protozoal activities *.

Article Snippet: ∆ 9 -Tetrahydrocannabinol (Δ 9 -THC) , MIC: 2–5 μg/mL against Staphylococcus aureus ATCC 6538 MIC: 1 μg/mL against Staphylococcus aureus ATCC 25923 MIC: 2 μg/mL against Staphylococcus aureus SA-1199B (NorA overexpression) MIC: 2 μg/mL against Staphylococcus aureus EMRSA-15 MIC: 0.5 μg/mL against Staphylococcus aureus EMRSA-16 MIC: 2 μg/mL against MRSA USA300 MIC: 4–8 μg/mL against MRSA ATCC 43300 MIC: 5 μg/mL against Streptococcus pyogenes MIC: 2 μg/mL against Streptococcus milleri MIC: 5 μg/mL against Streptococcus faecalis MIC: 4–8 μg/mL against Neisseria gonorrhoeae ATCC 19424 IC 50 : 4.8 μM against Staphylococcus aureus ATCC 29213 IC 50 : 6.9 μM against Bacillus cereus IIIM 25 IC 50 : 2.8 μM against Lactococcus lactis MTCC 440 IC 50 : 3.5 μM against Shigella boydii NC-09357 IC 50 : 6.4 μM against Staphylococcus warneri MTCC 4436 No effect against Escherichia coli , Salmonella typhi or Proteus vulgaris , [ , , , , ] .

Techniques: Cannabis, Activity Assay, Over Expression

In vitro antimicrobial bioassay of actinomycetia extracts against model pathogens and MDR pathogens: ( A ) Antimicrobial activity by spot inoculation (I,II) and well diffusion method (III–V) against model pathogens: (I) Candida albicans (MTCC 227). (II,III) MRSA (ATCC 43300). (IV) Klebsiella pneumonia (MTCC 3384); (V) Pseudomonas aeruginosa (MTCC 741). ( B ) Bioactivity of fermentation broth of actinomycetia isolates against model pathogens, based on triplicate experiments. ( C ) Antimicrobial activity by well diffusion method against MDR pathogens: (I,II) Pseudomonas aeruginosa . (III–V) Enterococcus faecalis . (VI–VIII) Escherichia coli . ( D ) Bioactivity of fermentation broth of actinomycetia isolates against 3 MDR pathogens, based on triplicate experiments, against: GNR7; Enterococcus faecalis ; GNR18; Pseudomonas aeruginosa ; and GNR19; Escherichia coli .

Journal: Metabolites

Article Title: Potentiality of Actinomycetia Prevalent in Selected Forest Ecosystems in Assam, India to Combat Multi-Drug-Resistant Microbial Pathogens

doi: 10.3390/metabo13080911

Figure Lengend Snippet: In vitro antimicrobial bioassay of actinomycetia extracts against model pathogens and MDR pathogens: ( A ) Antimicrobial activity by spot inoculation (I,II) and well diffusion method (III–V) against model pathogens: (I) Candida albicans (MTCC 227). (II,III) MRSA (ATCC 43300). (IV) Klebsiella pneumonia (MTCC 3384); (V) Pseudomonas aeruginosa (MTCC 741). ( B ) Bioactivity of fermentation broth of actinomycetia isolates against model pathogens, based on triplicate experiments. ( C ) Antimicrobial activity by well diffusion method against MDR pathogens: (I,II) Pseudomonas aeruginosa . (III–V) Enterococcus faecalis . (VI–VIII) Escherichia coli . ( D ) Bioactivity of fermentation broth of actinomycetia isolates against 3 MDR pathogens, based on triplicate experiments, against: GNR7; Enterococcus faecalis ; GNR18; Pseudomonas aeruginosa ; and GNR19; Escherichia coli .

Article Snippet: Recently, similar findings were reported, where EA-Kz-24 exhibited the lowest MIC against MRSA ATCC 43,300 and Candida albicans MTCC 227 (0.024 μg/mL) [ ].

Techniques: In Vitro, Bioassay, Activity Assay, Diffusion-based Assay

 MIC  (µg/mL) of the ethyl acetate extract of three potent actinomycetia strains by broth dilution method.

Journal: Metabolites

Article Title: Potentiality of Actinomycetia Prevalent in Selected Forest Ecosystems in Assam, India to Combat Multi-Drug-Resistant Microbial Pathogens

doi: 10.3390/metabo13080911

Figure Lengend Snippet: MIC (µg/mL) of the ethyl acetate extract of three potent actinomycetia strains by broth dilution method.

Article Snippet: Recently, similar findings were reported, where EA-Kz-24 exhibited the lowest MIC against MRSA ATCC 43,300 and Candida albicans MTCC 227 (0.024 μg/mL) [ ].

Techniques: Bacteria